Clinical trial
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap…
NCT00004091 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004091 |
|---|---|
| Title | Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results |
| Official title | Development of Antibody-Based Diagnostic Markers for Abnormal Cervical Cells |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cervical Cancer |
| Intervention type | Other, Procedure |
| Interventions | Papanicolaou test, cytology specimen collection procedure, fluorescent antibody technique, colposcopic biopsy, study of high risk factors |
| Enrollment | 100 |
| Start date | Aug 1, 1999 |
| Primary completion | Feb 1, 2001 |
| Completion | Feb 1, 2001 |
| First posted | Mar 1, 2004 |
| Last update posted | Jan 31, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: